Empresa Imv Inc Toronto S.E.
Acciones
CA45254B1031
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Andrew Hall
CEO | Chief Executive Officer | - | 10/11/20 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | - | |
Stéphane Fiset
CTO | Chief Tech/Sci/R&D Officer | - | - |
Annie Tanguay
CMP | Compliance Officer | - | - |
Jeremy Graff
CTO | Chief Tech/Sci/R&D Officer | - | 14/06/21 |
Delphine Davan
IRC | Investor Relations Contact | - | 01/08/19 |
Linda Barabe
IRO | Public Communications Contact | - | - |
Ryan Marshall
PRN | Corporate Officer/Principal | - | 01/01/16 |
General Counsel | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 58 | 01/07/20 | |
Kyle Kuvalanka
BRD | Director/Board Member | 56 | 01/04/21 |
Markus Warmuth
BRD | Director/Board Member | 53 | 06/11/18 |
Shabnam Kazmi
BRD | Director/Board Member | - | 08/01/23 |
Andrew Hall
CEO | Chief Executive Officer | - | 10/11/20 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
Michael Kalos
BRD | Director/Board Member | 62 | 11/05/21 |
Saman Maleki
BRD | Director/Board Member | - | 15/09/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 11 711 637 | 11 703 501 ( 99,93 %) | 0 | 99,93 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,96 % | 47,02 mil M | |
+48,77 % | 41,86 mil M | |
+1,17 % | 41,76 mil M | |
-4,27 % | 28,8 mil M | |
+11,42 % | 26,05 mil M | |
-21,39 % | 19,15 mil M | |
+4,86 % | 12,55 mil M | |
+27,29 % | 12,34 mil M | |
-3,50 % | 11,82 mil M |